Insight Molecular Diagnostics (IMDX) Cash from Investing Activities Growth (3y) (2018 - 2026)
Insight Molecular Diagnostics (IMDX) Cash from Investing Activities Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.70 Bn | 209.63 Bn | 8.34 Bn | 33.33% |
| 2 | Danaher | 140.15 Bn | 135.80 Bn | 3.61 Bn | -188.86% |
| 3 | Idexx Laboratories | 46.31 Bn | 46.11 Bn | 779.09 Mn | 2.46% |
| 4 | Agilent Technologies | 39.74 Bn | 37.93 Bn | 990.00 Mn | 0.00% |
| 5 | Iqvia Holdings | 39.38 Bn | 37.30 Bn | 1.44 Bn | 13.86% |
| 6 | Natera | 38.78 Bn | 37.68 Bn | 696.04 Mn | -59.07% |
| 7 | Illumina | 29.96 Bn | 28.79 Bn | 770.00 Mn | -48.84% |
| 8 | Mettler Toledo International | 28.60 Bn | 28.55 Bn | 650.22 Mn | 64.36% |
| 9 | Quest Diagnostics | 26.26 Bn | 25.64 Bn | 1.03 Bn | 41.86% |
| 10 | Insight Molecular Diagnostics | 171.73 Mn | 142.80 Mn | 15,000.00 | 23.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.55% |
| Dec 31, 2025 | -22.63% |
| Sep 30, 2025 | -6.92% |
| Jun 30, 2025 | 32.16% |
| Mar 31, 2025 | 41.85% |
| Dec 31, 2024 | 19.40% |
| Sep 30, 2024 | 39.56% |
| Jun 30, 2024 | 66.08% |
| Mar 31, 2024 | 85.74% |
| Dec 31, 2023 | 30.19% |
| Sep 30, 2023 | 34.01% |
| Jun 30, 2023 | 26.56% |
| Mar 31, 2023 | 39.48% |
| Dec 31, 2022 | 12.95% |
| Sep 30, 2022 | 57.56% |
| Jun 30, 2022 | -366.68% |
| Mar 31, 2022 | -227.77% |
| Sep 30, 2021 | -252.44% |
| Jun 30, 2021 | -560.30% |
| Mar 31, 2021 | -1,082.72% |